The Efficacy of Antifibrinolytic Therapy in Aneurysmal Subarachnoid Hemorrhage: a Systematic Review and meta-analysis

References

• EtminanN , ChangH-S , HackenbergKet al.Worldwide incidence of aneurysmal subarachnoid hemorrhage according to region, time period, blood pressure, and smoking prevalence in the population: a systematic review and meta-analysis. JAMA Neurol.76(5), 588–597 (2019).
   PubMed Web of Science ®Google Scholar
• BaharogluMI , GermansMR , RinkelGJEet al.Antifibrinolytic therapy for aneurysmal subarachnoid haemorrhage. Cochrane Database Syst. Rev.2013(8), CD001245 (2013).
   PubMedGoogle Scholar
• NieuwkampDJ , SetzLE , AlgraA , LinnFHH , de RooijNK , RinkelGJE. Changes in case fatality of aneurysmal subarachnoid haemorrhage over time, according to age, sex, and region: a meta-analysis. Lancet Neurol.8(7), 635–642 (2009).
   PubMed Web of Science ®Google Scholar
• SchatloB , FungC , StienenMNet al.Incidence and outcome of aneurysmal subarachnoid hemorrhage: the Swiss study on subarachnoid hemorrhage (Swiss SOS). Stroke52(1), 344–347 (2021).
   PubMed Web of Science ®Google Scholar
• LordAS , FernandezL , SchmidtJMet al.Effect of rebleeding on the course and incidence of vasospasm after subarachnoid hemorrhage. Neurology78(1), 31–37 (2012).
   PubMed Web of Science ®Google Scholar
• StarkeRM , KimGH , FernandezAet al.Impact of a protocol for acute antifibrinolytic therapy on aneurysm rebleeding after subarachnoid hemorrhage. Stroke39(9), 2617–2621 (2008).
   PubMed Web of Science ®Google Scholar
• SuarezJI. Diagnosis and management of subarachnoid hemorrhage. Contin. Minneap. Minn.21(5), 1263–1287 (2015).
   PubMedGoogle Scholar
• HigginsJPT , AltmanDG , GotzschePCet al.The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. Br. Med. J.343(2), d5928–d5928 (2011).
   PubMed Web of Science ®Google Scholar
• WellsG , SheaB , O'ConnellDet al.The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses (2013). http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp
   Google Scholar
• ChandraB. Treatment of subarachnoid hemorrhage from ruptured intracranial aneurysm with tranexamic acid: a double-blind clinical trial. Ann. Neurol.3(6), 502–504 (1978).
   PubMed Web of Science ®Google Scholar
• GelmersHJ. Prevention of recurrence of spontaneous subarachnoid haemorrhage by tranexamic acid. Acta Neurochir. (Wien)52(1–2), 45–50 (1980).
   PubMed Web of Science ®Google Scholar
• HillmanJ , FridrikssonS , NilssonO , YuZ , SavelandH , JakobssonK-E. Immediate administration of tranexamic acid and reduced incidence of early rebleeding after aneurysmal subarachnoid hemorrhage: a prospective randomized study. J. Neurosurg.97(4), 771–778 (2002).
   PubMed Web of Science ®Google Scholar
• VermeulenM , LindsayKW , MurrayGDet al.Antifibrinolytic treatment in subarachnoid hemorrhage. N. Engl. J. Med.311(7), 432–437 (1984).
   PubMed Web of Science ®Google Scholar
• van RossumJ , WintzenAR , EndtzLJ , SchoenJH , de JongeH. Effect of tranexamic acid on rebleeding after subarachnoid hemorrhage: a double-blind controlled clinical trial. Ann. Neurol.2(3), 238–242 (1977).
   PubMed Web of Science ®Google Scholar
• Maurice-WilliamsRS. Prolonged antifibrinolysis: an effective non-surgical treatment for ruptured intracranial aneurysms?Br. Med. J.1(6118), 945–947 (1978).
   PubMedGoogle Scholar
• RoosY. Antifibrinolytic treatment in subarachnoid hemorrhage: a randomized placebo-controlled trial. STAR Study Group. Neurology54(1), 77–82 (2000).
   PubMed Web of Science ®Google Scholar
• KasteM , RamsayM. Tranexamic acid in subarachnoid hemorrhage. A double-blind study. Stroke10(5), 519–522 (1979).
   PubMed Web of Science ®Google Scholar
• TsementzisSA , HitchcockER , MeyerCH. Benefits and risks of antifibrinolytic therapy in the management of ruptured intracranial aneurysms. A double-blind placebo-controlled study. Acta Neurochir. (Wien)102(1–2), 1–10 (1990).
   PubMed Web of Science ®Google Scholar
• PostR , GermansMR , TjerkstraMAet al.Ultra-early tranexamic acid after subarachnoid haemorrhage (ULTRA): a randomised controlled trial. Lancet397(10269), 112–118 (2021).
   PubMed Web of Science ®Google Scholar
• FodstadH , ForssellA , LiliequistB , SchannongM. Antifibrinolysis with tranexamic acid in aneurysmal subarachnoid hemorrhage: a consecutive controlled clinical trial. Neurosurgery8(2), 158–165 (1981).
   PubMed Web of Science ®Google Scholar
• PostR , GermansMR , BoogaartsHDet al.Short-term tranexamic acid treatment reduces in-hospital mortality in aneurysmal sub-arachnoid hemorrhage: a multicenter comparison study. PloS ONE14(2), e0211868 (2019).
   PubMed Web of Science ®Google Scholar
• GaberelT , MagheruC , EmeryE , DerlonJ-M. Antifibrinolytic therapy in the management of aneurismal subarachnoid hemorrhage revisited. A meta-analysis. Acta Neurochir. (Wien)154(1), 1–9 (2012).
   PubMed Web of Science ®Google Scholar
• HvasCL , HvasAM. Hemostasis and fibrinolysis following aneurysmal subarachnoid hemorrhage: a systematic review on additional knowledge from dynamic assays and potential treatment targets. Semin. Thromb. Hemost.48(03), 356–381 (2022).
   PubMed Web of Science ®Google Scholar
• RoosYBWEM , RinkelGJE , VermeulenM , AlgraA , van GijnJ. Antifibrinolytic therapy for aneurysmal subarachnoid hemorrhage. Cochrane Database Syst. Rev. (2), CD001245 (2003).
   PubMedGoogle Scholar
• ConnollyES , RabinsteinAA , CarhuapomaJRet al.Guidelines for the management of aneurysmal subarachnoid hemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke43(6), 1711–1737 (2012).
   PubMed Web of Science ®Google Scholar
• ZipfelGJ. Editorial: ultra-early surgery for aneurysmal subarachnoid hemorrhage. J. Neurosurg.122(2), 381–382 (2015).
   PubMed Web of Science ®Google Scholar
• RoosYB , BeenenLF , GroenRJet al.Timing of surgery in patients with aneurysmal subarachnoid haemorrhage: rebleeding is still the major cause of poor outcome in neurosurgical units that aim at early surgery. J. Neurol. Neurosurg. Psychiatry63, 490–493 (1997).
   PubMed Web of Science ®Google Scholar
• AllenGS , AhnHS , PreziosiTJet al.Cerebral arterial spasm--a controlled trial of nimodipine in patients with subarachnoid hemorrhage. N. Engl. J. Med.308(11), 619–624 (1983).
   PubMed Web of Science ®Google Scholar
• RodríguezDR , MatamorosCS , CúeLF , HernándezJLM , SánchezYP , NellarJP. Factors associated with poor outcome for aneurysmal subarachnoid haemorrhage in a series of 334 patients. Neurol. Barc. Spain32(1), 15–21 (2017).
   Google Scholar
• AvdagicSS , BrkicH , AvdagicH , SmajicJ , HodzicS. Impact of comorbidity on early outcome of patients with subarachnoid hemorrhage caused by cerebral aneurysm rupture. Med. Arch.69(5), 280–283 (2015).
   PubMedGoogle Scholar
• SlettebøH , KaricT , SortebergA. Impact of smoking on course and outcome of aneurysmal subarachnoid hemorrhage. Acta Neurochir. (Wien)162(12), 3117–3128 (2020).
   PubMed Web of Science ®Google Scholar
• DanièreF , GascouG , Menjotde Champfleur Net al.Complications and follow up of subarachnoid hemorrhages. Diagn. Interv. Imaging96(7–8), 677–686 (2015).
   PubMed Web of Science ®Google Scholar
• AndersenCR , PresseauJ , SaigleV , EtminanN , VergouwenMDI , EnglishSW. Core outcomes for subarachnoid haemorrhage. Lancet Neurol.18(12), 1075–1076 (2019).
   PubMed Web of Science ®Google Scholar